Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it's rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this paper we discuss the technical aspects of the radia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyran, Marguerite, Gonzague, Laurence, Bouabdallah, Reda, Resbeut, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977569/
https://www.ncbi.nlm.nih.gov/pubmed/24772357
http://dx.doi.org/10.1155/2014/427613
_version_ 1782310443370414080
author Tyran, Marguerite
Gonzague, Laurence
Bouabdallah, Reda
Resbeut, Michel
author_facet Tyran, Marguerite
Gonzague, Laurence
Bouabdallah, Reda
Resbeut, Michel
author_sort Tyran, Marguerite
collection PubMed
description Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it's rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this paper we discuss the technical aspects of the radiation therapy and histological issues. The new fields reductions proposed for classical Hodgkin lymphoma cannot be applied to early stages Nodular Lymphocyte Predominant Hodgkin lymphomas which are usually treated with radiation therapy without systemic chemotherapy.
format Online
Article
Text
id pubmed-3977569
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39775692014-04-27 Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma Tyran, Marguerite Gonzague, Laurence Bouabdallah, Reda Resbeut, Michel Case Rep Hematol Case Report Localized Nodular Lymphocyte Predominant Hodgkin Lymphoma is a rare disease with an overall good prognosis but frequent late relapses. Due to it's rarity there is no standard therapeutic approach and pathological diagnosis may be hard. In this paper we discuss the technical aspects of the radiation therapy and histological issues. The new fields reductions proposed for classical Hodgkin lymphoma cannot be applied to early stages Nodular Lymphocyte Predominant Hodgkin lymphomas which are usually treated with radiation therapy without systemic chemotherapy. Hindawi Publishing Corporation 2014 2014-02-20 /pmc/articles/PMC3977569/ /pubmed/24772357 http://dx.doi.org/10.1155/2014/427613 Text en Copyright © 2014 Marguerite Tyran et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tyran, Marguerite
Gonzague, Laurence
Bouabdallah, Reda
Resbeut, Michel
Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
title Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
title_full Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
title_fullStr Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
title_full_unstemmed Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
title_short Open Questions in the Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma
title_sort open questions in the management of nodular lymphocyte predominant hodgkin lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977569/
https://www.ncbi.nlm.nih.gov/pubmed/24772357
http://dx.doi.org/10.1155/2014/427613
work_keys_str_mv AT tyranmarguerite openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma
AT gonzaguelaurence openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma
AT bouabdallahreda openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma
AT resbeutmichel openquestionsinthemanagementofnodularlymphocytepredominanthodgkinlymphoma

Ejemplares similares